Impact of sleep apnea on heart health in patients with atrial fibrillation
Official title: Prospective Study on Obstructive Sleep Apnea and Cardiovascular Outcomes in Patients With Atrial Fibrillation and High Cardiovascular Risk
Run by National University of Singapore · NCT04005508 · Data updated 2026-11-12
This study is testing how sleep apnea affects heart health in people with atrial fibrillation to see if it changes their risk of heart problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 22 Years to 99 Years |
| Sex | All |
| Enrollment | 1365 (estimated) |
| Sponsor | National University of Singapore Academic / other |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | July 1, 2019 |
| Main results expected | June 30, 2025 |
| Study ends | June 30, 2028 |
| Registry record updated | June 12, 2024 |
| Trial ID | NCT04005508 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 22 and above with known atrial fibrillation and high cardiovascular risk factors.
✕Probably not a fit
Patients who are already on regular CPAP treatment for known obstructive sleep apnea may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The POACH study aims to investigate how obstructive sleep apnea (OSA) affects cardiovascular outcomes in patients with atrial fibrillation (AF) who are at high cardiovascular risk. This prospective, observational study will recruit 1365 patients in Singapore, using a home-based sleep study to classify participants based on the presence of OSA. Patients will receive standard AF management, and follow-up assessments will occur every six months for up to two years. The study will also analyze blood samples to measure various metabolites that may provide insights into cardiovascular health.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of cardiovascular risks in patients with atrial fibrillation and sleep apnea.
How similar studies have gone: While the relationship between OSA and cardiovascular outcomes is being explored, this specific approach in patients with AF is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 22 or above 2. Known AF, including paroxysmal, persistent or permanent AF 3. High cardiovascular risk, defined as one or more of the following: * hypertension * diabetes mellitus * stroke * significant coronary artery disease (at least one stenosis of \>50% diameter in at least one major epicardial artery based on CT or conventional coronary angiography, positive stress test \[treadmill, myocardial perfusion scan, or stress echocardiography\], previous percutaneous coronary intervention, or previous coronary artery bypass surgery) * chronic kidney disease (excluding polycystic kidney disease) with an estimated glomerular filtration rate of \<60 ml/min/1.73m2, * 10-year risk of cardiovascular disease of 15% or greater on the basis of the Framingham risk score, or * age of 75 years or older Exclusion Criteria: 1. Known OSA on regular CPAP treatment 2. Valvular AF (moderate/severe mitral stenosis or mechanical heart valve) 3. Permanent pacemaker implantation 4. Life expectancy less than 1 year based on concomitant medical conditions 5. Unable to give research consent 6. Pregnant or lactating women
Where it's running
-
Chi-Hang Lee
Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Chi-Hang R Lee, MD — National University of Singapore
- Study coordinator: Shalini Lobo, BSc
- Email: shalilb@nus.edu.sg
- Phone: 67795555
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Testing and treating sleep apnea in patients with atrial fibrillation
This study tests whether a new program for diagnosing and treating sleep apnea can help people with atrial fibrillation feel better and reduce their heart rhythm problems.
-
Investigating Atrial Fibrosis in Patients with Obstructive Sleep Apnea
This study is trying to see if people with obstructive sleep apnea are more likely to develop atrial fibrosis compared to those without the condition.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.